Recent Advances in HFrEF Roundtable

The emergence of new therapies for heart failure with reduced ejection fraction (HFrEF) present significant advances in the management of patients with HFrEF. They also present new questions and challenges for the cardiovascular community.

The Roundtable serves as a valuable forum for all the participants to delve deep into the practical issues facing clinicians in every day practice. Given the broad range of medical specialists who deliver care to patients with HFrEF, the goal is to draw on the collective experience and wisdom of the participants to explore gaps in implementation on current guideline directed medical therapy (GDMT), novel approaches to optimizing breakthrough therapies, and analyze structural inequalities in heart failure care.

Through the interactive discussion, the ACC aims to gather recommendations for establishing next steps around the development of clinical tools and patient resources to improve care and maximize the impact of new technologies and systemic changes in heart failure management.